Zimmer India eyes up to 15% revenue growth in FY15

Medical devices firm Zimmer India today said it is looking at up to 15% growth in revenues for the current financial year amounting to Rs 250 crore.

"We are looking at a growth of around 15% in the current fiscal year. The revenues would be around Rs 250 crore," Zimmer India Managing Director Sanjay Banerjee told PTI.

This is in line with the growth of nearly Rs 1,200 crore Indian orthopaedic market which is expected to grow between 12 to 15%, he added.

Banerjee was speaking on the sidelines of a media round table on 'Medical Devices in India: A New Lens, A New Regime' organised by association of medical devices manufacturers, AdvaMed.

Zimmer India is wholly owned subsidiary of US-based global musculoskeletal health solutions provider Zimmer Holdings.

When asked about the major drivers of growth of the company, Banerjee said: "Our growth is linked to the growth of Indian healthcare service sector in our segment and the major drivers for this are awareness, trained surgeons, access to facilities, affordability and market appropriate products."

Zimmer offers a comprehensive range of orthopaedic products - knee replacement and hip replacement products, shoulder surgery products, dental implants, trauma products, spine surgery products, foot and ankle systems, hand and wrist surgery products, biologics solutions among others.